ホーム › 乳がん › アリゾナ州 › Scottsdale
Scottsdale、AZにおける乳がんの臨床試験
Scottsdaleとその周辺地域（約30マイル以内）の拠点で、乳がんに関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
被験者募集中第2相
- Mayo Clinic, Scottsdale
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
被験者募集中第3相
- Mayo Clinic, Scottsdale
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
被験者募集中第3相
- Ironwood Cancer & Research Centers, Scottsdale
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer
被験者募集中第2相
- Mayo Clinic in Arizona, Scottsdale
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
被験者募集中
- Honor Health Research Institute, Scottsdale
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
被験者募集中第3相
- Mayo Clinic, Scottsdale
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
被験者募集中第1相
- Mayo Clinic of Scottsdale, Scottsdale
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
被験者募集中第1相
- HonorHealth, Scottsdale
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
被験者募集中第2相
- Mayo Clinic in Arizona, Scottsdale
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
被験者募集中第1相
- HonorHealth Research Institute, Scottsdale
Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
被験者募集中第2相
- Mayo Clinic in Arizona, Scottsdale
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
被験者募集中第3相
- Mayo Clinic - Scottsdale, Scottsdale
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
被験者募集中第2相
- Mayo Clinic - Scottsdale, Scottsdale
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
被験者募集中第3相
- Ironwood Cancer & Research Centers, Scottsdale
Cancer Genetic Testing in Ethnic Populations
被験者募集中
- Mayo Clinic in Arizona, Scottsdale
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
被験者募集中第1相
- HonorHealth Research Institute, Scottsdale
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
被験者募集中第4相
- Scottsdale Medical Imaging, LLC, Scottsdale
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Scottsdale
他の都市における乳がんの試験
- New York City, NY136件の研究
- Houston, TX126件の研究
- Boston, MA112件の研究
- Nashville, TN81件の研究
- Los Angeles, CA73件の研究
- Edison, NJ68件の研究
- St. Louis, MO64件の研究
- Queens, NY64件の研究
- Durham, NC64件の研究
- Chicago, IL59件の研究
- Philadelphia, PA56件の研究
- Dallas, TX55件の研究
Scottsdaleにおける他の研究
- がん（全種類）18件の研究
- 転移性癌17件の研究
- 前立腺がん17件の研究
- 大腸癌16件の研究
- 非小細胞肺癌15件の研究
- 膵臓がん13件の研究
- 悪性黒色腫10件の研究
- 潰瘍性大腸炎8件の研究
- 肺がん8件の研究
- 肝臓がん（肝細胞がん）7件の研究
- アルツハイマー病7件の研究
- トリプルネガティブ乳がん7件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。